Yes, rapid improvement in glycemic control with any diabetes medication can occasionally trigger treatment-induced neuropathy of diabetes, which presents as acute painful neuropathy and typically improves over time
This strategy is miles away from synthetic hormones and it does have some practical considerations
1 Mechanism of Action Bimagrumab is a monoclonal antibody targeting activin type II receptors, blocking binding of myostatin and activin A
Wegovy is administered as a subcutaneous injection once weekly, into the abdomen, thigh, or upper arm
Victoza (liraglutide) is FDA-approved to reduce the risk of major cardiovascular events like heart attack, stroke, and cardiovascular death in adults with type 2 diabetes and known heart disease
Antiepileptika : Das Antiepileptikum Valproinsure interagiert in vielfltiger Weise mit dem Carnitin-Stoffwechsel, was einen Mangel an L-Carnitin zur Folge haben kann